Contactos
Información
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers...
mostra más
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
mostra menos
21 OCT. 2024 · Is our time quickly becoming the era of “psychedelic McCarthyism”? If we’re not careful, that’s where it looks like we’re heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD.
Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.
The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation.
This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.
- Instagram: https://www.instagram.com/hamiltonmorris/
- Hamilton’s Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeia
- The Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
30 SEP. 2024 · In this episode, Dr. Dave Rabin and Dr. Jonathan Edwards tackle the controversial topic of ketamine in light of the tragic death of actor Matthew Perry. Together, they explore the safety profile of ketamine, its legitimate uses in treating depression and suicidal ideation, and dispel misinformation regarding its association with Perry's passing.Dr. Edwards, a leading expert in ketamine-assisted therapy and author of The Revolutionary Ketamine, offers his insights on the pressing need for effective mental health treatments. As suicide rates continue to rise, particularly among young people, this episode emphasizes the potential of ketamine as a life-saving treatment and the importance of therapy in conjunction with medication.Tune in to gain a deeper understanding of ketamine’s role in mental health and how it can potentially save lives.
- https://www.amazon.com/Revolutionary-Ketamine-Effectively-Depression-Prevents-ebook/dp/B0BTZ6Q9KY?author-follow=B0C831QBX3
- https://www.amazon.com/Stopping-Pain-Percutaneous-%C2%B7cu%C2%B7ta%C2%B7ne%C2%B7ous-Revolutionary/dp/B0CSKFQTF6
- http://www.johnathanedwardsmd.com
- https://johnathanedwardsmd.substack.com/publish/home
- Web: https://psychedelic.support/
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
11 SEP. 2024 · How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer.
Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.
Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.
https://podcasts.apple.com/us/podcast/optimizing-psychedelic-medicine-experiences-with-shawn/id1670195179?i=1000656299705
- Web: https://shawnwells.com/
- Instagram:https://www.instagram.com/shawnwells
- Twitter: https://twitter.com/DrDavidRabin
- Instagram:https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
- Web: http://www.apolloneuro.com
28 AGO. 2024 · In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.
Rachel Nuwer’s Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/
Jon Lubecky’s Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAo
- Web: https://psychedelic.support/
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
9 AGO. 2024 · In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.
John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.
Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.
Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.
Brain Health in Exeter, New Hampshire (http://www.brain-health.co/)
Psychiatric Times (http://www.psychiatrictimes.com/)
https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
https://www.linkedin.com/in/jjmillermd/
https://www.linkedin.com/company/psychiatric-times/
http://www.apolloneuro.com
FDA petition for MDMA-assisted therapy
https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
5 AGO. 2024 · In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje’s report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.
The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/
- Web: https://psychedelic.support/
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
25 JUL. 2024 · In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.
Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.
To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.
Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193
- Web: https://heroicheartsproject.org/our-story/
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
- Web: http://www.apolloneuro.com
10 JUL. 2024 · In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.
- Instagram: https://www.instagram.com/jonathanlubecky/
- Web: http://www.mdmaptsd.org
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
- Web: http://www.apolloneuro.com
Congressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda :
https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==
FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193
24 JUN. 2024 · In the latest episode of The Psychedelic Report, Dr. Dave Rabin shares the latest news on the MDMA-Assisted Therapy trials evaluation by the FDA Advisory Committee from June 4, who voted a surprising 10-1 that the risks of this breakthrough treatment outweigh the benefits. This was particularly astonishing to clinicians and researchers as described by Rachel Nuwer in her latest article in the BBC published on June 20. We’ll take a deep dive into this article and the discussion of safety and risks of MDMA-Assisted Therapy, followed by an enlightening conversation with award-winning author Tucker Max about his personal journey achieving a greater sense of safety with psychedelic-assisted therapy.
Tucker discusses the importance of safety and integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, psychotherapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.
Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.
Web: https://www.tuckermax.com/
Twitter: https://twitter.com/DrDavidRabin
Instagram:https://www.instagram.com/drdavidrabin
Web:https://www.drdave.io/
Web: https://www.ApolloNeuro.com
Tucker’s Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.
Article: FDA advisors voted against MDMA therapy – researchers are still fighting for it
https://www.bbc.com/future/article/20240620-fda-advisors-voted-against-mdma-therapy-researchers-are-still-fighting-for-it
Your Brain Explained Episode 1 - The MDMA Breakthrough: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=0377e20f02ed481d
Rachel Nuwer’s NYT article breaking the study findings: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html
Nature Medicine MDMA trial science article 1:https://www.nature.com/articles/s41591-021-01336-3
Nature Medicine MDMA trial science article 2: https://www.nature.com/articles/s41591-023-02565-4
Special episode of The Tim Ferriss Show with Dr. Dave Rabin on MDMA Therapy: https://open.spotify.com/show/5qSUyCrk9KR69lEiXbjwXM
Food and Drug Administration
5630 Fishers Lane
Rm. 1061
Rockville, MD 20852
Docket No. FDA-2024-N-193
10 JUN. 2024 · In this compelling episode of The Psychedelic Report, Dr. Dave Rabin is joined by esteemed journalist Rachel Nuwer, renowned for breaking the pivotal story on the Phase 3 MDMA-assisted therapy trials for PTSD in The New York Times. Together, they delve into the recent contentious votes from the FDA Pharmacologic Advisory Committee, which advised against approving MDMA-assisted therapy despite robust evidence from clinical trials.
Rachel provides an insider's perspective on the committee's decision, expressing disappointment over the unreasonably high standards applied to MDMA-assisted therapy compared to other psychiatric medications. She and Dr. Rabin discuss the committee's focus on issues like demographic representation and the integration of therapy with MDMA treatment, arguing that these criticisms overlook the proven benefits of MDMA in enhancing psychotherapy outcomes.
The episode highlights the need for better education on psychedelic therapy within the medical community and critiques the media's role in spreading public misconceptions. Rachel and Dr. Rabin emphasize the potential of MDMA-assisted therapy to revolutionize PTSD treatment, especially for Veterans and other underserved populations. Despite the setback, they remain hopeful that the scientific evidence and patients’ needs will ultimately prevail.
Overall, the conversation underscores the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust in these innovative treatments.
Your Brain Explained - Can We Cute Mental Illness? The MDMA Story
Apple: https://podcasts.apple.com/us/podcast/your-brain-explained/id1693658383?i=1000617879818
Spotify:
https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=fd8c315823854dad
Rachel Nuwer’s Breaking News on MDMA Phase 3 Trials Results in the NYT:
https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html
Rachel Nuwer’s book I Feel Love: MDMA and the Quest for Connection in a Fractured World https://www.goodreads.com/book/show/62039306-i-feel-love
Twitter: https://twitter.com/DrDavidRabin
Instagram: https://www.instagram.com/drdavidrabin
Web: https://www.drdave.io/
Web: www.ApolloNeuro.com
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers...
mostra más
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
mostra menos
Información
| Autor | Straw Hut Media |
| Organización | Straw Hut Media |
| Categorías | Medicina , Salud mental , Medicina alternativa |
| Página web | www.thepsychedelic.report |
| hello@strawhutmedia.com |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
